
Vriglim-VG 3 Tablet SR
Marketer
Vridam Healthcare Pvt Ltd
Salt Composition
Glimepiride (3mg) + Metformin (500mg) + Voglibose (0.3mg)
Overview Vriglim-VG 3 Tablet SR
GlucoBalance 3 SR tablets are classified as anti-diabetic medications. This combination therapy is indicated for adult patients with type 2 diabetes mellitus to manage blood glucose control. GlucoBalance 3 SR should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial, even with well-managed blood sugar, as discontinuation without medical consultation risks elevated glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication forms part of a comprehensive diabetes management plan, necessitating adherence to a healthy diet, regular physical activity, and weight management as directed by your doctor. Lifestyle factors significantly influence diabetes control. Hypoglycemia (low blood sugar) is the most prevalent side effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, fruit juice) are essential for prevention. Alcohol consumption should be minimized due to its hypoglycemic effect. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, edema, blurred vision, fractures, and upper respiratory infections. Weight gain may occur in some patients. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals should consult their doctor. Regular blood glucose monitoring and periodic blood tests to assess blood cell counts and liver function are recommended.
Primary Ingredients of Vriglim-VG 3 Tablet SR
No information provided. Please provide the text you wish me to rephrase.
Uses of Vriglim-VG 3 Tablet SR
Managing type 2 diabetes
Major Benefits of Vriglim-VG 3 Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Vriglim-VG 3 Tablet SR on an empty stomach.
Common Side effects of Vriglim-VG 3 Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Vriglim-VG 3 Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Vriglim-VG 3 Tablet SR on an empty stomach.
How Vriglim-VG 3 Tablet SR works:
Vriglim-VG 3 extended-release tablets contain a triple combination of antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Vriglim-VG 3 Tablet SR is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using Vriglim-VG 3 Tablet SR during pregnancy might pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Vriglim-VG 3 Tablet likely poses a risk during lactation. Available human data indicate potential transfer to breast milk, possibly harming the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyUNSAFE
Patients with kidney disease should likely avoid Vriglim-VG 3 Tablet SR, as its use is considered unsafe. A physician's consultation is advised. Furthermore, this medication is not recommended for those with severely impaired kidney function.
LiverCAUTION
Patients with liver impairment should use Vriglim-VG 3 Tablet SR cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, Vriglim-VG 3 Tablet SR is typically initiated at a reduced dosage; however, its use is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Vriglim-VG 3 Tablet SR :
Should you forget to take a Vriglim-VG 3 Tablet SR, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Vriglim-VG 3 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
